AMA: FDA action on OTC naloxone will save people from overdoses

Statement attributable to:
Patrice A. Harris, MD, MA
President-elect, chair of the AMA Opioid Task Force
American Medical Association

“The AMA applauds the FDA and Commissioner Gottlieb for today’s action to provide labeling that would allow for over-the-counter availability of naloxone, a move that will save people from opioid-related overdose. Naloxone has saved tens of thousands of lives, and the AMA continues to strongly urge physicians to co-prescribe naloxone to patients at risk of opioid-related overdose.